{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:54:01Z","timestamp":1758048841810,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbrc.2021.11.063","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:27:36Z","timestamp":1637317656000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["NF-\u03baB suppression synergizes with E7386, an inhibitor of CBP\/\u03b2-catenin interaction, to block proliferation of patient-derived colon cancer spheroids"],"prefix":"10.1016","volume":"586","author":[{"given":"Yusuke","family":"Kanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Ohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Owa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7587-0164","authenticated-orcid":false,"given":"Koji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.11.063_bib1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2021.11.063_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2021.11.063_bib3","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2021.11.063_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2021.11.063_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: relevance to cancer stem cells and clinical applications","volume":"108","author":"Ishiguro","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2021.11.063_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/0008-5472.CAN-15-0361","article-title":"Establishment and characterization of an in\u00a0vitro model of ovarian cancer stem-like cells with an enhanced proliferative capacity","volume":"76","author":"Ishiguro","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2021.11.063_bib7","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/0008-5472.CAN-11-3812","article-title":"Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells","volume":"72","author":"Ohata","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2021.11.063_bib8","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1158\/0008-5472.CAN-20-0378","article-title":"Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer","volume":"80","author":"Shiokawa","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2021.11.063_bib9","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1038\/ncomms12586","article-title":"TNIK inhibition abrogates colorectal cancer stemness","volume":"7","author":"Masuda","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2021.11.063_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2021.08.018","article-title":"Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance","volume":"521","author":"Yamawaki","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2021.11.063_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2021.11.063_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","article-title":"Mutations and mechanisms of WNT pathway tumour suppressors in cancer","volume":"21","author":"Bugter","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2021.11.063_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/mol.119.117978","article-title":"Wnt signaling and drug resistance in cancer","volume":"97","author":"Zhong","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.11.063_bib14","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1073\/pnas.0404875101","article-title":"A\u00a0small molecule inhibitor of beta-catenin\/CREB-binding protein transcription [corrected]","volume":"101","author":"Emami","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2021.11.063_bib15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/0008-5472.CAN-20-0782","article-title":"A\u00a0selective inhibitor of the interaction between \u03b2-catenin and CBP, exerts antitumor activity in tumor models with activated canonical Wnt signaling","volume":"81","author":"Yamada","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2021.11.063_bib16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.celrep.2019.06.085","article-title":"NOX1-Dependent mTORC1 activation via S100A9 oxidation in cancer stem-like cells leads to colon cancer progression","volume":"28","author":"Ohata","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2021.11.063_bib17","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2021.11.063_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stemcr.2019.08.015","article-title":"ALDH-dependent glycolytic activation mediates stemness and paclitaxel resistance in patient-derived spheroid models of uterine endometrial cancer","volume":"13","author":"Mori","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2021.11.063_bib19","first-page":"2021","article-title":"SynergyFinder Plus: towards a better interpretation and annotation of drug combination screening datasets","author":"Zheng","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2021.11.063_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2021.11.063_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.11.063_bib22","doi-asserted-by":"crossref","first-page":"986048","DOI":"10.1155\/2014\/986048","article-title":"Advanced heat map and clustering analysis using heatmap3","volume":"2014","author":"Zhao","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2021.11.063_bib23","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/cas.13969","article-title":"Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study","volume":"110","author":"Sunami","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2021.11.063_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2021.11.063_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-inducible factors: master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends Canc."},{"key":"10.1016\/j.bbrc.2021.11.063_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.11.063_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","article-title":"Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation","volume":"571","author":"Shin","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2021.11.063_bib28","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.bmcl.2007.08.022","article-title":"A\u00a0novel class of potent NF-kappaB signaling inhibitors","volume":"17","author":"Leban","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2021.11.063_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ncb1010-926","article-title":"HIF hits Wnt in the stem cell niche","volume":"12","author":"Kaufman","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.11.063_bib30","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI84433","article-title":"Hypoxia-dependent regulation of inflammatory pathways in immune cells","volume":"126","author":"Taylor","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.11.063_bib31","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2021.11.063_bib32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1158\/2159-8290.CD-19-1536","article-title":"Lineage reversion drives WNT independence in intestinal cancer","volume":"10","author":"Han","year":"2020","journal-title":"Cancer Discov."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21015783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21015783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:12:52Z","timestamp":1757765572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21015783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":32,"alternative-id":["S0006291X21015783"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.11.063","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NF-\u03baB suppression synergizes with E7386, an inhibitor of CBP\/\u03b2-catenin interaction, to block proliferation of patient-derived colon cancer spheroids","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.11.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}